 BOULDER, Colo., March 25, 2021 GLOBE NEWSWIRE -- Viridian Therapeutics, Inc. NASDAQ: VRDN, a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by todays therapies, today announced financial results for the fourth quarter and year ended December 31, 2020 and provided corporate updates. 